Renal Behcet's Disease: An Update

dc.contributor.authorAkpolat, Tekin
dc.contributor.authorDilek, Melda
dc.contributor.authorAksu, Kenan
dc.contributor.authorKeser, Goekhan
dc.contributor.authorToprak, Oemer
dc.contributor.authorCirit, Mustafa
dc.contributor.authorAkpolat, Ilkser
dc.date.accessioned2026-08-12T17:45:27Z
dc.date.issued2008
dc.departmentFırat Üniversitesi
dc.description.abstractObjective: The aims of this study are (1) to report 33 patients with Behcet's disease (BD) having various renal manifestations, and (2) to update Current data using our patients and published papers about BD and renal manifestations. Methods: The PubMed database was searched using the terms BD or Behcet's syndrome. We found reports of 94 patients (including ours) with BD and specific renal diseases (amyloidosis, 39; glomerulonephritis [GN], 37; renal vascular disease, 19; interstitial nephritis, 1). Results: The presentation of renal disease was edema/nephrotic syndrome in 12 patients (36%). Renal disease was incidentally diagnosed by routine Urine analysis and measurement Of Serum creatinine level in 20 patients (61 %). Renal failure was present in 23 patients (70%) and 5 of them have had cyclosporine treatment. The frequency of renal disease among BD patients has been reported to vary from less than 1 to 29%. Conclusions: The clinical spectrum OF renal BD shows a wide variation. Amyloidosis (AA type), GN, and macroscopic/microscopic vascular disease are the main causes of renal BD. Patients with vascular involvement have a high risk of amyloidosis and amyloidosis is the most common cause of renal failure in BD. Several types of glomerular lesions are seen in BD. Current treatment options for renal BD are not evidence based. Radiological vascular intervention combined with immunosuppressive drugs can be useful in selected cases. Routine Urine analysis and measurement of serum creatinine level are needed Cor early diagnosis of renal BD. (C) 2008 Elsevier Inc. All rights reserved. Semin Arthritis Rheum 38:241-248
dc.identifier.doi10.1016/j.semarthrit.2007.11.001
dc.identifier.endpage248
dc.identifier.issn0049-0172
dc.identifier.issn1532-866X
dc.identifier.issue3
dc.identifier.orcid0000-0002-0936-8691
dc.identifier.orcid0000-0001-7091-5204
dc.identifier.orcid0000-0001-8736-4779
dc.identifier.orcid0000-0002-2865-1687
dc.identifier.orcid0000-0001-8889-2688
dc.identifier.orcid0000-0003-3104-9205
dc.identifier.pmid18221990
dc.identifier.scopus2-s2.0-56349142092
dc.identifier.scopusqualityQ1
dc.identifier.startpage241
dc.identifier.urihttps://doi.org/10.1016/j.semarthrit.2007.11.001
dc.identifier.urihttps://hdl.handle.net/11508/60684
dc.identifier.volume38
dc.identifier.wosWOS:000261622100007
dc.identifier.wosqualityQ1
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherW B Saunders Co-Elsevier Inc
dc.relation.ispartofSeminars in Arthritis and Rheumatism
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzKA_WoS_20260511
dc.subjectBehcet's disease
dc.subjectamyloidosis
dc.subjectglomerulonephritis
dc.subjectrenal vascular disease
dc.subjectinterstitial nephritis
dc.subjectcyclosporine
dc.subjecturemia
dc.titleRenal Behcet's Disease: An Update
dc.typeReview Article

Dosyalar